MNPR · Company research
Monopar Therapeutics Inc. Common Stock (MNPR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| After a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. - Stock Titan | After a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. - Stock Titan | For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| 4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). - Stock Titan | 4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| 16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. - Stock Titan | 16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| (MNPR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily | (MNPR) Price Dynamics and Execution-Aware Positioning Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 26, 2026 | neutral | 0 | 0.6 |
| Monopar Therapeutics stock trades on a clinical pipeline catalyst - ad-hoc-news.de | Monopar Therapeutics stock trades on a clinical pipeline catalyst ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Sep 23, 2026 | neutral | 0 | 0.6 |
| Companies Like Monopar Therapeutics (NASDAQ:MNPR) Can Afford To Invest In Growth - Simply Wall Street | Companies Like Monopar Therapeutics (NASDAQ:MNPR) Can Afford To Invest In Growth Simply Wall Street | View source ↗ | Simply Wall Street | Aug 24, 2026 | neutral | 0 | 0.6 |
| Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’ - Seeking Alpha | Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’ Seeking Alpha | View source ↗ | Seeking Alpha | Aug 18, 2026 | neutral | 0 | 0.6 |
| Monopar downgraded to Neutral at Cantor (MNPR:NASDAQ) - Seeking Alpha | Monopar downgraded to Neutral at Cantor (MNPR:NASDAQ) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 13, 2026 | neutral | 0 | 0.6 |
| Monopar: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy) - Seeking Alpha | Monopar: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 17, 2026 | neutral | 0 | 0.6 |
| (MNPR) Movement as an Input in Quant Signal Sets - Stock Traders Daily | (MNPR) Movement as an Input in Quant Signal Sets Stock Traders Daily | View source ↗ | Stock Traders Daily | Jul 13, 2026 | neutral | 0 | 0.6 |
| Monopar Therapeutics: ALXN1840's Bull Case Has Improved (NASDAQ:MNPR) - Seeking Alpha | Monopar Therapeutics: ALXN1840's Bull Case Has Improved (NASDAQ:MNPR) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 3, 2026 | neutral | 0 | 0.6 |
| Monopar Therapeutics Insiders Make Handsome Sum Selling Stock At US$67.15 Per Share - Simply Wall Street | Monopar Therapeutics Insiders Make Handsome Sum Selling Stock At US$67.15 Per Share Simply Wall Street | View source ↗ | Simply Wall Street | Jun 29, 2026 | neutral | 0 | 0.6 |
| MNPR Forecast — Price Target — Prediction for 2027 - TradingView | MNPR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 27, 2026 | neutral | 0 | 0.6 |
| Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade - Yahoo Finance | Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade Yahoo Finance | View source ↗ | Yahoo Finance | Jun 15, 2026 | neutral | 0 | 0.6 |
| MNPR Stock Rallies After Hours As Experimental Drug Shows Rapid Copper Balance Improvement In Genetic Disorder - Stocktwits | MNPR Stock Rallies After Hours As Experimental Drug Shows Rapid Copper Balance Improvement In Genetic Disorder Stocktwits | View source ↗ | Stocktwits | May 19, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 26, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.